Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by a spina bifida pregnancy

Molecular Genetics and Metabolism

Volumn 65, Issue 1, 1998, Pages 18-30

  Lucock, M D ^a   Daskalakis, I ^a   Lumb, C H ^a   Schorah, C J ^a   Levene, M I ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLIC ACID; TETRAHYDROFOLIC ACID;

ARTICLE; CELL REGENERATION; DIET SUPPLEMENTATION; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FOLIC ACID DEFICIENCY; GENE MUTATION; HUMAN; HUMAN CELL; HYDROLYSIS; METHYLATION; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; PURINE SYNTHESIS; SPINA BIFIDA;

EID: 0031769901     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2738     Document Type: Article

References (29)

1. Lancet. 338:1991;131-137.
2. Cziezel A E, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med. 327:1992;1832-1835.
3. Laurence K M, James N, Miller M, Tennant G B, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ. 282:1981;1509-1511.
4. Smithells R W, Nevin N C, Seller M J, Sheppard S, Harris R, Read A P, Fielding D W, Walker S, Schorah C J, Wild J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1:1983;1027-1031.
5. Kirke P N, Daly L E, Elwood J H. A randomised trial of low dose folic acid to prevent neural tube defects. Arch Dis Child. 67:1992;1442-1446.
6. Mills J L, Scott J M, Kirke P N, McPartlin J M, Conley M R, Weir D G, Molloy A M, Lee Y J. Homocysteine and neural tube defects. J Nutr. 126:1996;7565-7605.
7. Ubbink J B. Is an elevated circulating maternal homocysteine concentration a risk factor for neural tube defects? Nutr Rev. 53:1995;172-175.
8. Whitehead A S, Gallagher P, Mills J L, Kirke P N, Burke H, Molloy A M, Weir D G, Shields D C, Scott J M. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Quart J Med. 88:1995;763-766.
9. Van der Put N MJ, Steegers-Theunissen R PM, Frosst P, Trijbels F JM, Eskes T KAB, Van der Heuvel L P, Mariman E CM, Den Heur M, Roger R, Blom H J. Lancet. 346:1995;1070.
10. Kirke P N, Molloy A M, Daly L E, Burke H, Weir D G, Scott J M. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Quart J Med. 86:1993;703-708.
11. Lucock M D, Wild J, Lumb C H, Oliver M, Kendall R, Daskalakis I, Schorah C J, Levene M I. Risk of neural tube defect affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydrofolate: Homocysteine methyltransferase. Biochem Mol Med. 61:1997;28-40.
12. Lucock M D, Lumb C H, Wild J, Oliver M, Daskalakis I, Schorah C J, Kendall R, Levene M I. Elevated homocysteine in subjects with a previous NTD pregnancy is associated with increased hexaglutamyl methylfolate consistent with impaired B12 dependent methionine synthase activity. Chemistry and Biology of Pteridines and Folates 1997. 1997;Blackwell, Oxford. p. 297-302.
13. Lucock M D, Lumb C H, Wild J, Oliver M, Daskalakis I, Schorah C J, Kendall R, Levene M I. Methionine synthase activity is dependent upon intracellular methylfolate levels in control but not NTD subjects where utilisation of hexaglutamyl methylfolate is limiting for remethylation of homocysteine. Pfleiderer W, Rokos H. Chemistry and Biology of Pteridines and Folates 1997. 1997;321-324 Blackwell, Oxford.
14. Lucock M D, Daskalakis I, Schorah C J, Levene M I, Hartley R. Analysis and biochemistry of blood folate. Biochem Mol Med. 58:1996;93-112.
15. Stover P, Schirch V. The metabolic role of leucovorin. TIBS. 18:1993;102-106.
16. Lucock M D, Green M, Priestnall M, Daskalakis I, Levene M I, Hartley R. Optimisation of chromatographic conditions for the determination of folates in foods and biological tissues for nutritional and clinical work. Food Chem. 53:1995;329-338.
17. Lucock M D, Priestnall M, Daskalakis I, Schorah C J, Wild J, Levene M I. Non-enzymatic degradation and salvage of dietary folate: Physicochemical factors likely to influence bioavailability. Biochem Mol Med. 55:1995;43-53.
18. Paquin J, Baugh C M, MacKenzie R E. Channeling between the active sites of formiminotransferase-cyclodeaminase. J Biol Chem. 260:1985;14925-14931.
19. Daskalakis I, Lucock M D, Anderson A, Wild J, Schorah C J, Levene M I. Determination of plasma total homocysteine and cysteine using hplc with fluorescence detection and an SBDF derivatisation protocol optimised for antioxidant concentration, derivatisation reagent concentration, temperature and matrix pH. Biomed Chromatogr. 10:1996;205-212.
20. Molloy A M, Ramsbottom D, McPartlin J, Whitehead A S, Weir D G, Scott J M. 5,10-Methylenetetrahydrofolate reductase C677T genotypes and folate related risk factors for neural tube defects. Pfleiderer W, Rokos H. Chemistry and Biology of Pteridines and Folates 1997. 1997;291-296 Blackwell, Oxford.
21. Girgis S, Suh J R, Jolivet J, Stover P J. 5-Formyltetrahydrofolate regulates homocysteine remethylation in human nueroblastoma. J Biol Chem. 272:1997;4729-4734.
22. Schorah C J, Devitt H, Lucock M D, Dowell A C. The responsiveness of plasma homocysteine to small increases in dietary folic acid: A primary care study. Eur J Clin Nutr. 52:1998;407-411.
23. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitamins Hormones. 45:1989;263-335.
24. Mills J L, McPartlin J M, Kirke P N, Lee Y J, Conley M R, Weir D G, Scott J M. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet. 345:1995;149-151.
25. Steegers-Theunissen, R, PM, Homocysteine, Vitamins and Neural Tube Defects, 1993, 74.
26. Smithells R W, Schorah C J, Seller M J, Nevin N C, Harris R, Read A P, Fielding D W. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet. 1:1980;339-340.
27. Li Y N, Gulati S, Baker P J, Brody L C, Banerjee R, Kruger W D. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet. 5:1996;1851-1858.
28. Leclerc D, Campeau E, Goyette P, Adjalla C E, Christensen B, Ross M, Eydoux P, Rosenblatt D S, Rozen R, Gravel R A. Human methionine synthase cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet. 5:1996;1867-1874.
29. Van Der Put N MJ, Van Der Molen E F, Kluijtmans L AJ, Heil S G, Trijbels J MF, Eskes T KAB, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom H J. Sequence analysis of the coding region of human methionine synthase: Relavence to hyperhomocysteinaemia in neural tube defects and vascular disease. Quart J Med. 90:1997;511-517.